GENZYME CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 128 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-05-22: Reporting owner MOSCICKI RICHARD A; Form 4; Security Genzyme NQ Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-05-22: Reporting owner Meeker David P; Form 4; Security Genzyme NQ Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-05-22: Reporting owner GERAGHTY JAMES A; Form 4; Security Genzyme NQ Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-05-22: Reporting owner DesRosier Thomas; Form 4; Security Genzyme NQ Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-05-22 | MOSCICKI RICHARD A Officer (Senior Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,250 24,250 owned after | $68.48 exercise price | 2008-05-27 | |
| 2008-05-22 | Meeker David P Officer (President LSD Therapeutics) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $68.48 exercise price | 2008-05-27 | |
| 2008-05-22 | GERAGHTY JAMES A Officer (Senior Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $68.48 exercise price | 2008-05-27 | |
| 2008-05-22 | DesRosier Thomas Officer (Sr VP General Counsel) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $68.48 exercise price | 2008-05-27 | |
| 2008-05-22 | CSIMMA ZOLTAN A Officer (Senior VP, Human Resources) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $68.48 exercise price | 2008-05-27 | |
| 2008-05-22 | COLLIER EARL M JR Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $68.48 exercise price | 2008-05-27 | |
| 2008-05-22 | Bamforth Mark R Officer (Sr.VP, Corp. Operations & Phar) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $68.48 exercise price | 2008-05-27 | |
| 2008-05-22 | SYRON RICHARD F/CA Director | 4 | Genzyme DEP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $68.48 exercise price | 2008-05-23 | |
| 2008-05-22 | MCGILLICUDY CORNELIUS III Director | 4 | Genzyme DEP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $68.48 exercise price | 2008-05-23 | |
| 2008-05-22 | DZAU VICTOR J Director | 4 | Genzyme DEP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $68.48 exercise price | 2008-05-23 | |
| 2008-05-22 | COONEY CHARLES L Director | 4 | Genzyme DEP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $68.48 exercise price | 2008-05-23 | |
| 2008-05-22 | CARPENTER ROBERT J Director | 4 | Genzyme DEP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $68.48 exercise price | 2008-05-23 | |
| 2008-05-22 | BOUDREAUX GAIL Director | 4 | Genzyme DEP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $68.48 exercise price | 2008-05-23 | |
| 2008-05-22 | BERTHIAUME DOUGLAS A Director | 4 | Genzyme DEP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $68.48 exercise price | 2008-05-23 | |
| 2008-05-21 | BERTHIAUME DOUGLAS A Director | 4 | Genzyme DOP stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,000 0 owned after | $13.78 exercise price | 2008-05-23 | |
| 2008-05-02 | COONEY CHARLES L Director | 4 | Genzyme DOP stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,000 0 owned after | $32.52 exercise price | 2008-05-06 | |
| 2008-05-02 | COONEY CHARLES L Director | 4 | Genzyme DOP Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 0 owned after | $43.90 exercise price | 2008-05-06 | |
| 2008-03-03 | MCGILLICUDY CORNELIUS III Director | 4 | Genzyme DOP Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 9,000 owned after | $46.24 exercise price | 2008-03-05 | |
| 2008-03-03 | MCGILLICUDY CORNELIUS III Director | 4 | Genzyme DOP stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −890 0 owned after | $45.91 exercise price | 2008-03-05 | |
| 2008-03-03 | MCGILLICUDY CORNELIUS III Director | 4 | Genzyme DOP stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,010 0 owned after | $45.96 exercise price | 2008-03-05 | |
| 2008-03-03 | MCGILLICUDY CORNELIUS III Director | 4 | Genzyme DOP Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 0 owned after | $43.90 exercise price | 2008-03-05 | |
| 2008-01-17 | MOSCICKI RICHARD A Officer (Senior Vice President) | 4 | Genzyme NQ stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −45,793 59,836 owned after | $29.44 exercise price | 2008-01-22 | |
| 2008-01-16 | SMITH SANDFORD D Officer (Executive Vice President) | 4 | Genzyme NQ stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,300 14,700 owned after | $53.47 exercise price | 2008-01-18 | |
| 2008-01-16 | SMITH SANDFORD D Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,881 9,000 owned after | $46.24 exercise price | 2008-01-18 | |
| 2008-01-16 | COLLIER EARL M JR Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −90,000 0 owned after | $46.24 exercise price | 2008-01-18 | |
| 2008-01-11 | SMITH SANDFORD D Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,719 11,881 owned after | $46.24 exercise price | 2008-01-15 | |
| 2008-01-09 | SMITH SANDFORD D Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100 16,600 owned after | $46.24 exercise price | 2008-01-11 | |
| 2008-01-08 | MOSCICKI RICHARD A Officer (Senior Vice President) | 4 | Genzyme NQ stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −45,793 105,629 owned after | $29.44 exercise price | 2008-01-10 |